Scinnohub Pharmaceutical Co., Ltd.

This study tests a new drug, BT-114143, to see if it can reduce blood loss during knee replacement surgery better than the current standard treatment. About 270 adults having knee replacement will receive either a high or low dose of BT-114143 or tranexamic acid. The main goal is…

This early-stage study tests an investigational injection called BT-114143 in 39 women with abnormal uterine bleeding. The goal is to see if it is safe and can reduce menstrual blood loss. Participants will receive either the drug or a placebo, and their bleeding and quality of l…